Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 10: AMD II

11:00 - 12:30 | 06 September | Room: Room 241

Back to Previous

11:00Mineralocorticoid receptor invalidation in vascular endothelial cells prevents CNV development
M. Zhao France
11:06Pigment epithelial detachments in chronic central serous chorioretinopathy: effect of half-dose photodynamic therapy versus high-density subthreshold micropulse laser (PLACE trial report No. 5)
E. van Dijk Netherlands
11:12Effectiveness of intravitreal aflibercept in patients with neovascular age-related macular degeneration treated in routine practice – REALE Study
F. Cabrera López Spain
11:18Age-related macular degeneration prevalence and staging by color fundus photography vs multimodal imaging: the coimbra eye study
C. Farinha Portugal
11:24Phase 2b study of brimonidine dds: potential novel treatment for geographic atrophy
F. Bandello Italy
11:30Pharmacological antagonism of mineralocorticoid receptor exerts VEGF-independent anti-angiogenic effects: Implication for wet AMD
F. Behar-Cohen France
11:36Visual and expanded anatomical outcomes for brolucizumab versus aflibercept in patients with neovascular AMD: 96-week data from HAWK and HARRIER
F. Holz Germany
11:42Quantitative autofluorescence for the prediction of lesion growth in advanced age-related macular degeneration with solitary geographic atrophy
G. Reiter Austria
11:48Pachydrusen, choroidal vascular hyperpermeability, and punctate hyperfluorescent spots in polypoidal choroidal vasculopathy
H. Kang Korea, Republic of
11:54The effect of vitrectomy on the progression of dry age-related macular degeneration
I. Kilic Turkey
12:00Optimization of the port delivery system with ranibizumab (PDS) implant insertion procedure in the ladder phase 2 trial
J. Stewart United States
12:06Real-world data on endophthalmitis after intravitreal anti-vascular endothelial growth factor injections with or without topical antibiotic prophylaxis
J. Lok Hong Kong
12:12Comparison of one-year outcome of photodynamic therapy in combination with intravitreal aflibercept or ranibizumab for polypoidal choroidal vasculopathy
J. Wang Taiwan
12:18One year results with PRIMA, a photovoltaic wireless subretinal implant for advanced atrophic Dry Age-related Macular Degeneration
Y. Le Mer France
Back to Previous

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved